Press releases
- Press releases
- Browse
Press releases
The International Journal of Clinical Pharmacology and Therapeutics April 2009 Issue has published the latest peer-reviewed science on TDS-Testosterone. More
Two probiotic strains “GM-080” and “GMNL-33,” developed and marketed by GenMont Biotech Inc., (TWOTC: 3164) have been approved by regulatory agencies in China, and can now be used as additive ingredients to food products in that market. More
Protein drug development company Mycenax Biotech Inc. (GreTai, Taiwan: 4726) announced today that its rheumatoid arthritis and psoriasis drug TuNEX®, a biosimilar version of etanercept, has successfully completed a Phase I trial in South Korea and Phase I More
FDA ISSUED ORDERS TO SOLVAY AND AUXILIUM TO ADD BLACK BOX LABELS TO THEIR PRODUCTS AS NOTIFICATION TO USERS OF DANGER OF UNINTENDED TRANSFERENCE OF TESTOSTERONE TO FAMILY MEMBERS. TRANSDERMAL TECHNOLOGIES TDS-TESTOSTERONE'S RAPIDLY ABSORBED FORMULA WILL More
APR and the leading pharmaceutical company in Turkey Abdi Ibrahim have entered into an exclusive license agreement for the promotion, distribution and marketing of Ondansetron Rapidfilm® in Turkey; terms of the deal were not disclosed. More
FDA has approved Cambia™, Potassium Diclofenac Powder for Oral Solution for the treatment of acute migraine attacks with or without aura, originally developed by APR Applied Pharma Research SA (APR) using the patented Dynamic Buffering Technology (DBT). More
At a forum focusing on allergy causes and treatment strategies held in Taipei, botanically-derived health products company Medigreen Biotechnology unveiled its new anti-allergy formulation More
The U.S. FDA this week issued new guidelines for labeling of Non-Steroidal Anti-Inflammatory Drugs (NSAID) and Acetaminophen (Paracetemol) used for pain relief and fever reduction due to concerns about overdosing and co-administration with Alcohol. TDS wo More
Diabetics may soon be able to wear contact lenses that continuously alert them to variations in their glucose levels by changing colours - replacing the need to routinely draw blood throughout the day. More
Research being driven by The University of Western Ontario to enhance diabetes management across Canada has received $500,000 from two of Canada's leading pharmaceutical companies. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2010 - 11 pages - $75
May 2010 - 9 pages - $75
May 2010 - 9 pages - $75
May 2010 - 9 pages - $75
May 2010 - 9 pages - $75
May 2010 - 9 pages - $75
May 2010 - 9 pages - $75
May 2010 - 9 pages - $75
May 2010 - 9 pages - $75
May 2010 - 9 pages - $75
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us